Order Article Reprints

Parmar A, Dai WF, Dionne F, Geirnaert M, Denburg A, Ahuja T, Beca J, Bouchard S, Chambers C, Hunt MJ, et al. Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration. Current Oncology. 2023; 30(4):3776-3786. https://doi.org/10.3390/curroncol30040286

Parmar, Ambica, Wei Fang Dai, Francois Dionne, Marc Geirnaert, Avram Denburg, Tarry Ahuja, Jaclyn Beca, Sylvie Bouchard, Carole Chambers, Melissa J. Hunt, and et al. 2023. "Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration" Current Oncology 30, no. 4: 3776-3786. https://doi.org/10.3390/curroncol30040286

Parmar, A., Dai, W. F., Dionne, F., Geirnaert, M., Denburg, A., Ahuja, T., Beca, J., Bouchard, S., Chambers, C., Hunt, M. J., Husereau, D., Lungu, E., McDonald, V., Mercer, R. E., Mitera, G., Muñoz, C., Naipaul, R., Peacock, S., Potashnik, T., ... Chan, K. K. W. (2023). Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration. Current Oncology, 30(4), 3776-3786. https://doi.org/10.3390/curroncol30040286